← Open Payments lookup

NARENDIR SOORYA: Open Payments

NPI 1922021955 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,499 in 82 payments from 15 companies in 2025. Trend: 2023 $905 · 2024 $959 · 2025 $1,499

Food & beverage: $1,496Education: $4
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)21$332
Alkermes, Inc.9$174
ABBVIE INC.12$174
Vanda Pharmaceuticals Inc.7$168
Neurocrine BioSciences, Inc.7$157
E.R. Squibb & Sons, L.L.C.9$135
Otsuka America Pharmaceutical, Inc.4$86
UCB, Inc.2$62
Axsome Therapeutics, Inc.2$45
Supernus Pharmaceuticals, Inc.2$37

Products named: CAPLYTA, VRAYLAR, FANAPT, INGREZZA, ARISTADA, COBENFY, REXULTI, Qelbree.

Industry payments across MO — which companies pay providers there.